NVS


Incyte, Novartis Initiate Phase 3 Jakavi Drug Study For Coronavirus Treatment  

Global biotech company Incyte (INCY) announced on Friday that it has initiated a Phase 3 clinical trial in collaboration with Novartis (NVS) to …

Here’s Why AveXis (AVXS) Investors Are Celebrating Today

AveXis (NASDAQ:AVXS) investors are busy throwing a party today following the news that Novartis (NYSE:NVS) has reached an agreement to acquire AveXis for …

Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG (ADR) (NVS): Cowen Top Analyst

Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an …

Your Guide to Biotech M&A Monday

Some biopharma business development teams had a sleepless weekend. Four healthcare-related acquisitions were announced in quick succession on Monday morning, totaling about $18 billion …

DEALS AND RUMORS OF DEALS DOMINATED THIS WEEK IN HEALTHCARE

This week was a busy one for biopharma BD teams. Finallized on Sunday, Valeant (VRX) will pay $158 per share for Salix Pharmaceuticals (SLXP) in an all-cash …

Unilfe: New Contracts Will Triple Share Price

Update: This article is to update the recent announcements and run up in share price since the last article that we published on …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts